Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

Zeneca presents peptides for modifying autoimmune responses as in RA

July 27, 1998

Alexion's C5 inhibitor enters clinic for second autoimmune disorder

July 24, 1998

Dipeptidyl peptidase IV inhibitors developed at Tanabe

July 24, 1998

Antiinflammatory/immunomodulating peptide available for licensing from BTG

July 24, 1998

Daiichi team discloses ICAM-1 production inhibitors for inflammatory disorders

July 23, 1998

Sankyo prepares inhibitors of TNF-alpha production

July 23, 1998

HMR arthritis Rx up for FDA committee review

July 21, 1998

Invitation to access the ongoing telesymposium on rheumatoid arthritis therapies

July 17, 1998

Synthesis of new COX-2 inhibitor described by Merck scientists

July 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...